Submission Details
| 510(k) Number | K110296 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | February 01, 2011 |
| Decision Date | August 18, 2011 |
| Days to Decision | 198 days |
| Submission Type | Traditional |
| Review Panel | Immunology (IM) |
| Summary | Summary PDF |
K110296 is an FDA 510(k) clearance for the AXIS-SHIELD ANTI-CCP, a Antibodies, Anti-cyclic Citrullinated Peptide (ccp) (Class II — Special Controls, product code NHX), submitted by Axis-Shield Diagnostics, Ltd. (Dundee, Scotland, GB). The FDA issued a Cleared decision on August 18, 2011, 198 days after receiving the submission on February 1, 2011. This device falls under the Immunology review panel. Regulated under 21 CFR 866.5775.
| 510(k) Number | K110296 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | February 01, 2011 |
| Decision Date | August 18, 2011 |
| Days to Decision | 198 days |
| Submission Type | Traditional |
| Review Panel | Immunology (IM) |
| Summary | Summary PDF |
| Product Code | NHX — Antibodies, Anti-cyclic Citrullinated Peptide (ccp) |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 866.5775 |
| Definition | The Device Is Used For The Detection Of Anti-cyclic Citrullinated Peptide (ccp) Antibodies In Human Serum Or Plasma As An Aid In The Diagnosis Of Rheumatoid Arthritis. |